Document Type : Research Paper
School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran
Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran
Department of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran
Background and Objective: High prevalence of diabetes mellitus (DM) makes it an important comorbidity in patients with coronavirus disease (COVID-19). The objective of the current study was to compare morbidity and mortality between patients with diabetes and controls.
Method: This cross-sectional study was conducted in Imam Hossein hospital of Shahroud. A total of 184 patients with confirmed COVID-19 were included. Individuals with chronic underlying diseases such as cardiovascular diseases, hypertension, and pulmonary diseases were excluded. Then, patients were divided into two groups: patients with COVID-19 who also had DM, and individuals with COVID-19 who did not have a history of DM.
Results: The prevalence of high diastolic blood pressure (DBP) and fever were significantly more in the non-diabetes patients (prevalence DBP=10%, p value=0.05/ prevalence fever=65%, p value=0.01). Also, the mortality rate was slightly higher in non-DM patients (P =0.5). There was not any statistically significant difference between other clinical features and laboratory tests between the groups.
Conclusion: We found that DM patients with COVID-19 infection were not at a higher risk of mortality or poor outcome compared to the non-DM patients.